Core Insights - Haoxi Health Technology Limited (HAO) announced preliminary unaudited financial results for FY24, projecting significant revenue growth attributed to strategic developments in online advertising solutions, particularly in short video formats and news feed ads [1][2] Financial Performance - Revenue for FY24 is projected at approximately $48.52 million, reflecting a 72% increase from $28.23 million in FY23 [1] - Gross profit is estimated at approximately $2.75 million for FY24, a 33.4% increase from $2.06 million in FY23 [1] - Net income is projected to be approximately $1.29 million for FY24, marking a 33.2% increase from $0.97 million in FY23 [1] - Total assets increased to approximately $15.51 million as of June 30, 2024, up from $4.46 million at the end of FY23, indicating growth in operational scale and capital utilization post-IPO [1] Business Strategy and Market Position - Since its IPO in January 2024, HAO has consistently grown its core business, benefiting from the demand for targeted healthcare advertising in China [2] - The company aims to strengthen its position in the digital healthcare advertising market through established relationships with major media platforms and expertise in short video ad optimization [2] - HAO is committed to capitalizing on the expanding healthcare sector in China, focusing on ad placement strategies and enhancing service offerings [2][4]
Haoxi Health Technology Limited Announces Preliminary Unaudited FY24 Financial Results with projected 72% Revenue Growth